BioCryst Pharmaceuticals
BCRX
#4950
Rank
A$2.81 B
Marketcap
A$10.94
Share price
-2.67%
Change (1 day)
1.75%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

Volume in USD (price x number of shares), data since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$8.76 M79.92%
2025A$4.87 M63.48%
2024A$2.98 M14.07%
2023A$2.61 M-87.57%
2022A$21.02 M-74.17%
2021A$81.38 M69.16%
2020A$48.11 M440.33%
2019A$8.9 M100.99%
2018A$4.43 M-68.51%
2017A$14.06 M277.58%
2016A$3.72 M-78.39%
2015A$17.23 M10.36%
2014A$15.62 M95.45%
2013A$7.99 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Gilead Sciences
GILD
A$17.8 MA$79.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$56.53 MA$0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$4.05 MA$23 M๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$13.57 MA$60.84 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$12.79 MA$53.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$2.92 MA$12.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$0.03 MA$1.87 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$0.04 MA$1.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.65 MA$5.59 M๐Ÿ‡บ๐Ÿ‡ธ USA